![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Celgene Drops Crohn’s Disease Drug
Celgene Drops Crohn’s Disease Drug
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/red_blackpillsyellowbottle.jpg?t=1435771803&width=430)
Celgene abandoned development of its Crohn’s disease drug Revolve (mongersen) after disappointing results from a Phase III clinical trial.
The drug failed to pass muster in an interim futility analysis, the company said.
Celgene said it will continue development of other drugs for Crohn’s.
Upcoming Events
-
21Oct